Endemic nephropathy: The case for chronic poisoning by aristolochia

Croatian Medical Journal

Volumn 46, Issue 1, 2005, Pages 116-125

  Hranjec, Tjaša ^a   Kovač, Anamarija ^b   Kos, Jelena ^b   Mao, Wenyang ^a   Chen, John J ^a   Grollman, Arthur P ^a   Jelaković, Bojan ^c  

^a STONY BROOK UNIVERSITY   (United States)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c KBC Zagreb   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ARISTOLOCHIC ACID;

ADULT; AGED; ARISTOLOCHIA; ARTICLE; CANCER RISK; CHRONIC KIDNEY FAILURE; DIETARY INTAKE; ENDEMIC DISEASE; FEMALE; GEOGRAPHIC DISTRIBUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTERSTITIAL NEPHRITIS; INTOXICATION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PLANT SEED; UROGENITAL TRACT TUMOR; WHEAT; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; CHI SQUARE DISTRIBUTION; CHRONIC DISEASE; CROATIA; MIDDLE AGED; QUESTIONNAIRE;

ARISTOLOCHIA; BALKAN NEPHROPATHY; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; CROATIA; FEMALE; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES;

EID: 15744404859     PISSN: 03539504     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Dimitrov T. Balkan endemic nephropathy in Bulgaria. Facta Universitatis Series Medicine and Biology. 2002; 9:7-14.
2. Trnačević S, Halilbašić A, Imamović G, Mesić E. Balkan endemic nephropathy in Bosnia and Hercegovina. Facta Universitatis Series Medicine and Biology. 2002;9:31-3.
3. Čvorišćec D, Ćeović S, Stavljenić-Rukavina A. Endemic nephropathy in Croatia. Zagreb: Academia Croatica Scientiarum Medicarum; 1996.
4. Gluhovschi C, Margineanu F, Trandafirescu V, Schiller A, Petrica, L, Velciov S, et al. Balkan endemic nephropathy in Romania. Facta Universitatis Series Medicine and Biology. 2002;9:15-25.
5. Wolstenholme GE, Knight J, editors. Ciba Foundation Study Group No 30. The Balkan Nephropathy. Boston: Ciba Foundation; 1967.
6. Pichler O, Bobinac E, Miljuś B, Sindik A. Growing occurrence of kidney injuries in the district of Slavonski Brod [in Croatian]. Liječ Vjesn. 1959;81:295-306.
7. Radonić M. Epidemiology, clinic, histology, and etiology of endemic nephropathy in Yugoslavia [in French]. In: Richet G, editor. Proceedings of the 1st International Congress of Nephrology. Paris: International Society for Nephrology; 1961. p. 528-37.
8. Danilović V. Jovanović M. Batuta's unpublished manuscript about focus of chronic renal disease in Brestovac [in Serbian]. In: Collection of papers of the 3rd symposium on endemic nephropathy 1975. Belgrade: Dokumenta Galenika; 1977. p. 122-9.
9. Georgiev G. Clinical and genealogical investigation of Balkan endemic nephropathy [in Bulgarian] Sophia: Publishing House of the Bulgarian Academy of Science; 1979. p. 1-55.
10. Tatu CA, Orem WH, Finkelman RB, Feder GL. The etiology of Balkan endemic nephropathy: still more questions than answers. Environ Health Perspect. 1998;106: 689-700.
11. Djukanovic L, Radovanovic Z. Balkan endemic nephropathy. In: De Broe ME, Porter GA, Bennett WM, Verpooten GA, editors. Clinical nephrotoxins, 2nd ed. Dordrecht (The Netherlands): Kluwer Academic Publishers; 2003. p. 587-601.
12. Stefanović V, Cosyns JP. Balkan nephropathy. In: Davidson AM, Cameron JS, Grunfeld JP, Kerr D, Ritz E, Winearls CG, editors. Oxford textbook of clinical nephrology. 3rd ed. Oxford: Oxford University Press; In press 2004.
13. Dimitrov PS, Simeonov VA, Stein AD. Balkan endemic nephropathy in Vratza, Bulgaria, 1964-1987: an epidemiologic analysis of population-based disease registers. Eur J Epidemiol. 2001;17:847-53.
14. Bukvić D. Endemic nephropathy - review of studies in Lazarevac area. Lazarevac-Belgrade: Professional Pen Co Belgrade; 2004.
15. World Health Organization. Memorandum. The endemic nephropathy of South-Eastern Europe. Bull World Health Organ. 1965;32:441-8.
16. Voice TC, Long DT, Radovanović Z, Aktins JL, McElmurry SP, Niagolova N, et al. Critical evaluation of environmental exposure agents implicated in the etiology of Balkan endemic nephropathy. In: Proceedings of the 8th International Conference on Environmental Science and Technology. Lemnos Island: Soceity for Environmental Science and Technology; 2003.
17. Aleraj B. A study of the viral etiology of endemic nephropathy. In: Čvorišćec D, Čeović S, Stavljenić- Rukavina A, editors. Endemic nephropathy in Croatia. Zagreb: Academia Croatica Scientiarum Medicarum; 1996. p. 73-5.
18. Wedeen RP. Environmental renal disease: lead, cadmium and Balkan endemic nephropathy. Kidney Int Suppl. 1991;34:S4-8.
19. Maksimovic ZJ. Selenium deficiency and Balkan endemic nephropathy. Kidney Int Suppl. 1991;34:S12-4.
20. Čikeš N, Radošević Z, Vuletić S. Some population genetic aspects of endemic nephropathy. In: Strahinjić S, Stefanović V, editors. Proceedings of the 4th Symposium on Endemic (Balkan) Nephropathy. Niš (Serbia and Montenegro): University of Niš; 1979. p. 241-5.
21. Čeović S, Hrabar A, Radonić M. An etiological approach to Balkan endemic nephropathy based on the investigation of two genetically different populations. Nephron. 1985;40:175-9.
22. Codin M, Fillastre JP, Simon P, Francois A, Roy FL, Morin JP. Is ochratoxin A nephrotoxicin human beings? Adv Nephrol. 1997;26:181-206.
23. Pfohl-Leszkowicz A, Petkova-Bocharova T, Chernozemsky IN, Castegnaro M. Balkan endemic nephropathy and associated urinary tract tumours: a review on aetiological causes and the potential role of mycotoxins. Food Addit Contam. 2002;19:282-302.
24. Hult K, Fuchs R, Peraica M, Plestina R, Ceovic S. Screening for ochratoxin A in blood by flow injection analysis. J Appl Toxicol. 1984;4:326-9.
25. Pohl J. Aristolochin, a poisonous component of Aristolochia clematitis. In: Naunyn B, Schmiedeberg O, editors. Archiv für Experimentelle Pathologie und Pharmakologie [in German], Leipzig: Verlag von F C W Vogel. 1892. p. 282-301.
26. Ivić M. Etiology of endemic nephropathy. Lijec Vjesn. 1969;91:1273-81.
27. Dumić A. Horse poisoning with Aristolochia clematitis [in Croatian]. Zagreb: Izdanje Vojno tehničkog glasnika; 1954. p. 3-45.
28. Martinčić M. Toxic effects of Aristolochia clematitis on horses' kidneys [in German]. Vetererinarski Arhiv. 1957;27:51-9.
29. Ivié M, Lovrić B. Carcinogenic action of Aristolochia [in Serbian]. Acta Medica Medicine. 1967;5:1-3.
30. Arlt VM, Stiborova M, Schmeiser HH. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis. 2002;17:265-77.
31. IARC Monographs on the evaluation of carcinogenic risks to humans: Some traditional herbal medicines, some mycotoxins, naphthalene and styrene, Volume 82. World Health Organization, International Agency for Research on Cancer; 2002.
32. Chernozemsky IN, Stoyanov IS, Petkova-Bocharova TK, Nicolov IG, Draganov IV, Stoichev II, et ai. Geographic correlation between the occurrence of endemic nephropathy and urinary tract tumours in vratza district, Bulgaria, Int J Cancer. 1977;19:1-11.
33. Nikolov IG, Chernozemsky IN. Balkan endemic nephropathy and transitional cell carcinoma: two fatal chronic diseases and the environment. J Environ Pathol Toxicol Oncol. 1990;10:317-20.
34. Čeović S, Grims P, Mitar J. The incidnece of urinary tract tumors in the endemic nephropathy region and in a control area [in Croatian]. Lijec Vjesn. 1976;98:30l-4.
35. Čeović S, Miletić-Medved M. Epidemiological features of endemic nephropathy in the focal area of Brodska Posavina, Croatia. In: Čvorišćec D, Čeović S, Stavljenić- Rukavina A, editors. Endemic nephropathy in Croatia. Zagreb: Academia Croatica Scientiarum Medicarum; 1996. p. 7-21.
36. Petronić V. Tumors of the upper urothelium and endemic nephropathy. In: Radovanović Z, Sindjić M, Polenaković M, Djukanović Lj, Petronić V, editors. Endemic nephropathy. Belgrade: Zavod za udžbenike i nastavna sredstva; 2000. p. 350-439.
37. Djokić M, Hadzi-Djokić J, Nikolić J, Dragičević D, Radivojević D. Comparison of upper urinary tract tumors in the region of Balkan nephropathy with those of other regions of Yugoslavia. Prog Urol. 1999;9:61-8.
38. Li X, Yang L, Su T, Zou W, Wang H. Chinese herb Guanmutong-induced aristolochic acid nephropathy: clinical-pathological characteristics. Kidney Int. In press 2005.
39. Cosyns JP. Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date. Drug Safe. 2003;26:33-48.
40. Hu SY. An enumeration of Chinese materia medica. 2nd ed. Hong Kong: Chinese University of Hong Kong Press; 1999.
41. Mortier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med. 2000;342:1686-92.
42. Vanherweghem JL, Debelle F, Muniz-Martinez MC, Nortier J. Aristolochic acid nephropathy after Chinese herbal remedies. In: De Broe ME, Porter GA, Bennett VM, Verpooten GA, editors. Clinical nephrotoxins. Renal injury from drugs and chemicals. 2nd ed. Dordrecht (Nederland): Kliewer Academic Publishers; 2003. p. 579-86.
43. Vukelić M, Šoštarić B, Belicza M. Pathomorphology of Balkan endemic nephropathy. Food Chem Toxicol. 1992;30:193-200.
44. Ferluga D, Hvala A, Vizjak A, Trnacevic S, Halilbasic A. Renal function, protein excretion, and pathology of Balkan endemic nephropathy. III. Light and electron microscopic studies. Kidney Int Suppl. 1991;34:S57-67.
45. Čvorišćec D, Čeović S, Boršo G, Stavljenić-Rukavina AS. Endemic nephropathy in Croatia. Clin Chem Lab Med. 1998;36:271-7.
46. Radovanović Z. Diagnosis of endemic nephropathy. In: Radovanović Z, Sindjić M, Polenaković M, Djukanović Lj, Petronić V, editors. Endemic nephropathy. Belgrade: Zavod za udžbenike i nastavna sredstva; 2000. p 296-305.
47. Čeović S. Contribution to epidemiology of endemic nephropathy in Brodska Posavina [Master Thesis]. Zagreb: Zagreb University; 1971.
48. Miletić-Medved M. Report on water quality in the district of Brodska Posavina. Department for Public Health, District of Slavonski Brod. 2004 [in Croatian]. A document in possession of author.
49. Trinajstić I. Aristolochia L. In: Trinajstić I, editor. Analytical flora in Yugoslavia [in Croatian]. Zagreb: Institut za botaniku. University of Zagreb; 1973. p. 219.
50. Mengs U, Lang W, Poch J-A. The carcinogenic action of aristolochicacid in rats. Arch Toxicol. 1982;51:107-19.
51. Debelle FD, Nortier JL, De Prez EG, Garbar CH, Vienne AR, Salmon IJ, et al. Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats. J Am Soc Nephrol. 2002;13:431-6.
52. Evans WE, Johnson JA. Pharmacogenomics: the inherited basis for interindividual differences in drug response. Annu Rev Genomics Hum Genet. 2001;2:9-39.
53. Jelaković B, Sertić J, Čvorišćec D, Leko N, Stavljenić-Rukavina A, Kuzmanić D, et al. ACE gene polymorphism in endemic nephropathy patients on chronic hemodialysis. Periodicum Biologorum. 2000;102:73-6.
54. Arlt VM, Ferluga D, Stiborova M, Pfohl-Leszkowicz A, Vukelic M, Ceovic S, et al. Is aristolochic acid a risk factor for Balkan endemic nephropathy-associated urothelial cancer? Int J Cancer. 2002;101:500-2.